Pharmaceutical

Dyno and Roche collaborate on neurological gene therapies

Dyno has formed a new research partnership with Roche on the development of AAV gene therapy vectors for neurological diseases.

Oct 26, 2024 - 04:00
Dyno and Roche collaborate on neurological gene therapies
Dyno has formed a new research partnership with Roche on the development of AAV gene therapy vectors for neurological diseases.
Read the original article

Tags:

Previous Article

Sanofi-backed Agomab raises $89m to advance fibrotic disease treatments

Next Article

Takeda and BMC partner to decarbonise US healthcare sector

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Managing temperature-sensitive injectable drugs in fill finish operations

Managing temperature-sensitive injectable drugs in fill...

Sep 26, 2024

STAT+: The Q2 health tech tracker: 13 key industry events and milestones to watch

STAT+: The Q2 health tech tracker: 13 key industry even...

Apr 5, 2023

OptiBiotix Health gets grant for modified prebiotic oli...

Aug 23, 2024